OPRX— OptimizeRx Corp

Health Care$133M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net revenue	$109.4M+18.8%	$92.1M+28.8%	$71.5M+14.5%	$62.5M
Cost of revenues, exclusive of depreciation and amortization presented separately below	$35.8M+9.4%	$32.7M+14.4%	$28.6M+21.9%	$23.5M
Gross profit	$73.6M+23.9%	$59.4M+38.4%	$42.9M+10.1%	$39.0M
Operating expenses	—	—	—	—
Stock-based compensation	$7.0M-39.3%	$11.5M-16.4%	$13.7M-12.9%	$15.7M
Impairment charges	$368K-95.1%	$7.5M+11.1%	$6.7M	—
Depreciation and amortization	$4.3M-0.0%	$4.3M+80.2%	$2.4M+18.8%	$2.0M
Other general and administrative expenses	$50.2M+0.9%	$49.8M+12.4%	$44.3M	—
Total operating expenses	$61.9M-15.3%	$73.1M+5.5%	$69.3M+35.2%	$51.3M
Income (loss) from operations	$11.7M+185.3%	-$13.7M+48.1%	-$26.4M-114.8%	-$12.3M
Interest expense	-$5.3M+14.1%	-$6.2M-323.7%	-$1.5M	—
Other income	$198K+30.3%	$152K-69.6%	$500K	—
Interest income	$353K+7.3%	$329K-85.0%	$2.2M+157.2%	$852K
Total other expenses, net	-$4.7M+16.5%	-$5.7M-558.7%	$1.2M+45.3%	$852K
Income (loss) before provision for income taxes	$7.0M+135.9%	-$19.4M+23.0%	-$25.2M	—
Income tax expense	-$1.8M-150.8%	-$725K-109.5%	$7.6M	—
Net income (loss)	$5.1M+125.5%	-$20.1M-14.5%	-$17.6M-53.6%	-$11.4M
Weighted average number of shares outstanding – basic (in shares)	18.56B+1.4%	18.29B+6.8%	17.12B+96193.3%	17.8M
Weighted average number of shares outstanding – diluted (in shares)	19.00B+3.9%	18.29B+6.8%	17.12B+96193.3%	17.8M
Income (loss) per share – basic (in dollars per share)	$280.00+125.5%	-$1100.00-6.8%	-$1030.00-160837.5%	-$0.64
Income (loss) per share – diluted (in dollars per share)	$270.00+124.5%	-$1100.00-6.8%	-$1030.00-160837.5%	-$0.64

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.